NCT00003022View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 1997

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
Brain and Central Nervous System TumorsIntraocular MelanomaLung CancerMelanoma (Skin)NeuroblastomaRetinoblastomaSarcoma
Interventions
RADIATION

iodine I 131 monoclonal antibody 3F8

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER